VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
CCRN
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
CCRNCross Country Healthcare, Inc.
$13.22$427M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksCCRNCash Flow

Cross Country Healthcare, Inc. (CCRN) Cash Flow Statement

27Y historyFree accessUpdated daily

Despite recurring net losses, the company has preserved liquidity through consistent free cash flow generation, including $3.3M in 2026Q1, while continuing to deploy capital toward share repurchases.

CCRN Cash Flow Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMDec'25Dec'24Dec'23Dec'22Dec'21Dec'20Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09Dec'08Dec'07Dec'06Dec'05Dec'04Dec'03Dec'02Dec'01Dec'00Dec'99
Cash from Operations47.34M48.25M120.12M248.5M134.05M-85.62M27.2M5.54M21M45.51M30.14M18.23M-4.07M8.66M10.15M18.3M31.52M72.32M50.99M35.96M32.92M30.79M43.27M51.8M41.42M19.7M10.4M18.48M
Operating CF Margin %-4.58%8.94%12.3%4.78%-5.11%3.25%0.67%2.57%5.26%3.62%2.38%-0.66%1.98%2.29%3.63%6.73%12.51%6.94%5.01%5.02%4.77%6.61%7.54%6.47%3.94%2.83%9.54%
Operating CF Growth %33.55%-59.83%-51.66%85.38%256.57%-414.73%390.87%-73.61%-53.86%50.96%65.31%547.81%-147.03%-14.66%-44.55%-41.96%-56.41%41.82%41.79%9.25%6.91%-28.84%-16.47%25.05%110.23%89.5%-43.74%-
Net Income-98.63M0-14.56M72.63M185.98M132M-12.14M-55.94M-15.72M38.8M8.73M4.95M-31.53M-51.97M-42.22M4.1M-2.77M6.69M-142.94M24.58M16.64M14.75M20.66M25.82M29.78M8.67M4.6M11.54M
Depreciation & Amortization8.19M018.2M18.35M12.58M9.85M12.67M14.07M11.78M10.17M9.18M8.07M7.44M6.18M8.95M10.28M11.89M12.79M10.8M8.51M7.17M7.55M7.55M8.12M6.67M17.74M15.02M5.29M
Stock-Based Compensation1.64M06.03M6.58M7.39M6.89M5.4M3.4M3.58M4.08M3.38M2.46M1.39M2.1M2.59M2.9M2.66M1.96M1.23B046.8M115.66M62.7M47.03M0000
Deferred Taxes-617K0-1.94M1.3M5.11M-9.93M-932K31.16M-3.41M-33.81M-5.32M-1.54M-857K45.9M-18.52M3.05M5.38M9.24M-68.22M11.35M7.04M4.65M5.51M4.6M3.98M000
Other Non-Cash Items16.16M17.79M24.77M22.16M26.7M12.82M25.05M27.03M32.16M23.17M26.61M17.87M28.86M5.18M56.51M1.52M11.74M3.7M-983.41M2M-39.2M-112.45M-63.92M-44.41M655.18K10.58M4.73M1.65M
Working Capital Changes33.4M30.46M87.63M127.48M-103.71M-237.26M-2.85M-14.17M-7.39M3.1M-12.44M-13.57M-9.37M1.27M2.83M-3.55M2.62M37.93M4.7M-10.47M-5.52M634.83K10.77M10.64M332.68K-17.28M-13.95M0
Change in Receivables44.1M56.73M128.33M251.43M-153.23M-318.42M-4.75M-6.64M2.82M9.71M-30.78M-28.71M-16.12M2.04M-4.26M-7.97M5.46M47.74M19.26B0-3.67B-13.62B13.53B6.71B-6.87B000
Change in Inventory00000-83.29M-7.24M1.31M7.09M1.82M-1.53M3.55M1.03M319.23M-4.12B0011.36B-4.37B011.93B-9.55B-12.17B-8.7B4.51B000
Change in Payables919K-34.57M-29.75M-126.61M083.29M7.24M-1.31M-7.09M-9.28M20.37M11.21M5.65M-319.86M4.13B00-11.37B-14.88B0-8.34B23.1B-1.42B1.92B2.28B000
Cash from Investing-7.73M-8.16M-8.71M-13.78M-43.87M-34.05M-4.62M-2.94M-6.68M-91.38M-9.78M-24.07M-45.45M15.2M174.63K-4.2M-16.2M-10M-129.56M-35.33M-27.85M-8.41M4.01M-109.48M-18.57M-42.32M-9.58M1.17M
Capital Expenditures-7.73M-8.16M-8.71M-13.97M-8.79M-7.17M-4.62M-2.94M-4.6M-5.11M-6.52M-2.36M-4.57M-1.75M-2.22M-4M-2.39M-2.45M-4.69M-8.28M-9.31M-7.63M-4.62M-3.57M-7.24M-5.66M-1.99M0
CapEx % of Revenue0.77%0.77%0.65%0.69%0.31%0.43%0.55%0.36%0.56%0.59%0.78%0.31%0.74%0.4%0.5%0.79%0.51%0.42%0.64%1.15%1.42%1.18%0.71%0.52%1.13%1.13%0.54%-
Acquisitions000199K-35.09M-26.88M-1.15M-1.57M-2.08M-86.27M-3.26M-21.71M3.75M45.66M00-12.83M-7.55M-124.87M-27.05M-18.54M0-30.39K-105.95M-11.78M-34.95M-7.7M0
Investments----------------------------
Other Investing0000001.15M1.57M-151K-292K500K-338K-44.63M-28.7M-258.83K-197.91K-981.32K-748.24M-13.13B-35.33M-18.54B-785.34K8.65M44.65K456.64K-1.71M108.08K1.17M
Cash from Financing-14.74M-13.01M-46.85M-221.24M-87.6M119.09M-22.01M-17.6M-23.77M50.76M-2.16M3.35M46.46M-26.06M-10.58M-14.24M-11.19M-64.14M80.08M8.43M-5.07M-22.38M-47.28M40.47M-8.38M25.26M-5.64M-15.08M
Debt Issued (Net)000-150.68M32.34M127.68M-20.07M-14.96M-16.12M55.5M1.5M4.5M47.92M-25.76M-10.06M-11.78M-10.97M-70.75M89.69M17.14M-3.99M-19.16M-51.3M50.49M-6.41M-112.73M-5.64M0
Equity Issued (Net)-12.39M-6.83M-37.31M-57.65M-35.28M-2.23M-658K-801K-5M0000-300K-374K-2.23M00-10.78M-8.98M-1.47M-2.51M4.13M-6.7M-1.61M138.97M00
Dividends Paid000000000000-119K000000000000000
Share Repurchases-12.39M-6.83M-37.31M-57.65M-35.28M-2.23M-658K-801K-5M-1.77M0-543K-245K-300K-374K-2.23M00-10.78M-10.88M-2.76M-4.29M-446K-7.71M-6.01M000
Other Financing-2.35M-6.17M-9.54M-12.91M-84.65M-6.35M-1.28M-1.84M-2.64M-4.74M-3.66M-1.15M-1.46M-531-152.76K-221.6K-226.29K6.62M1.17M276.97K390.1K-712.88K-111.56K-3.33M-362.57K-981.83K0-15.08M
Net Change in Cash24.89M27.11M64.54M13.49M2.57M-564K568K-14.99M-9.52M4.91M18.18M-2.54M-3.06M-2.41M-185.34K-308.63K4.1M-1.6M1.11M8.43M00040.47M14.47M25.26M-5.64M-15.08M
Free Cash Flow39.6M40.09M111.4M234.52M125.26M-92.79M22.59M2.6M16.4M40.4M23.62M15.87M-8.64M6.91M7.93M14.3M29.13M69.87M46.3M27.69M23.61M23.16M38.65M48.23M34.18M14.04M8.4M18.48M
FCF Margin %3.95%3.8%8.29%11.61%4.47%-5.53%2.7%0.32%2.01%4.67%2.83%2.07%-1.4%1.58%1.79%2.84%6.22%12.08%6.31%3.85%3.6%3.59%5.91%7.02%5.34%2.81%2.29%9.54%
FCF Growth %-64.45%-64.01%-52.5%87.22%235%-510.77%768.14%-84.13%-59.4%71.01%48.83%283.65%-225.11%-12.85%-44.56%-50.92%-58.31%50.88%67.25%17.28%1.92%-40.07%-19.86%41.1%143.45%67.05%-54.52%-
FCF per Share1.261.243.346.613.34-2.480.630.070.461.120.650.49-0.280.220.260.460.942.251.490.850.720.711.191.481.020.560.360.80
FCF Conversion (FCF/Net Income)-0.40x-0.51x-8.25x3.42x0.72x-0.65x-2.10x-0.10x-1.24x1.21x3.78x4.13x0.13x-0.25x-0.24x4.46x-11.36x10.80x-0.36x1.46x1.98x2.09x2.09x2.01x1.39x2.27x2.26x1.60x
Interest Paid0007.53M12.86M5.77M2.67M4.55M6.34M3.41M3.89M5.05M2.51M622K1.47M2.13M3.52M5.01M3.81M000000000
Taxes Paid002.43M21.99M82.89M3.61M612K555K1.04M697K1.77M1.03M1.37M1.16M1.68M1.56M936.77K2.15M8.63M000000000

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetHealthy
Cash FlowMixed
Top Statement Risk

Structural Revenue Normalization

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q1)

Earnings Quality Masked by Volatility

According to reported financial data, CCRN consistently generates positive operating cash flow despite recurring net losses, with the OCF/NI ratio frequently reaching extreme negative values, such as -11.59 in 2025Q1, indicating that accounting earnings are currently a poor proxy for the company's actual cash-generating capacity.

The persistent divergence between net income and operating cash flow suggests that non-cash charges and working capital fluctuations are significantly distorting the bottom line. Investors should interpret this as a sign that the company's cash-generating engine remains functional even while the P&L reflects the ongoing cyclical downturn.

FCF Resilience Amid Revenue Decline

As reported in financial statements, CCRN has maintained positive free cash flow in every quarter over the last ten periods, peaking at $79.6M in 2024Q2, which demonstrates a surprising ability to preserve cash despite the broader contraction in the healthcare staffing market.

This FCF trajectory suggests that the company's business model is highly responsive to revenue shifts, allowing for rapid cost adjustments that protect liquidity. However, the volatility in FCF margins warrants caution, as the ability to sustain these levels depends heavily on the company's success in managing its variable cost base.

Working Capital as Cash Buffer

Based on the provided cash flow statements, working capital changes have frequently served as a primary source of liquidity, including a significant $75.2M inflow in 2024Q2, which has been instrumental in offsetting the impact of declining net income during the current industry cycle.

The reliance on working capital releases suggests that the company is effectively liquidating receivables as the business scales down. Analysts should monitor whether this source of cash is sustainable or if it represents a one-time benefit from the normalization of pandemic-era payment cycles.

Capital Allocation Prioritizes Shareholder Returns

As indicated by recent filings, CCRN has utilized its cash reserves to fund share repurchases, including $6.5M in 2025Q4, even while the company navigates a period of negative net margins and significant revenue contraction across its core staffing segments.

This deployment strategy suggests management maintains confidence in the company's long-term value despite current operational headwinds. Investors should evaluate whether these repurchases represent an efficient use of capital or if the funds would be better preserved to navigate the ongoing market volatility.

CCRN — Frequently Asked Questions

Quick answers to the most common questions about buying CCRN stock.

How much cash does Cross Country Healthcare, Inc. (CCRN) generate from operations?

Cross Country Healthcare, Inc. (CCRN) generated $48.3M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.

What is Cross Country Healthcare, Inc.'s free cash flow?

Cross Country Healthcare, Inc. (CCRN) generated $40.1M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.

What is Cross Country Healthcare, Inc.'s capital expenditure (CapEx)?

Cross Country Healthcare, Inc. (CCRN) spent $8.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.

How does Cross Country Healthcare, Inc. distribute cash to shareholders?

In 2025, Cross Country Healthcare, Inc. (CCRN) spent $6.8M on share repurchases. This shows the company's commitment to returning capital to its equity investors.